Live Breaking News & Updates on Globe Newswire Gt Biopharma Inc|Page 2

Stay updated with breaking news from Globe newswire gt biopharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split

GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Corey Davis , Company Board Of Directors , Globe Newswire Gt Biopharma Inc , Source Gt Biopharma Inc , Computershare Trust Company , University Of Minnesota , Company Special Meeting Of Stockholders , Exchange Commission , Company Board , Computershare Inc , Gt Biopharma Inc , Nasdaq Capital Market , Minimum Bid Price Requirement , Nasdaq Capital , Special Meeting , Common Stock ,

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote "FOR" All Proposed Items at the Upcoming Special Meeting of Stockholders

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote "FOR" All Proposed Items at the Upcoming Special Meeting of Stockholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Corey Davis , Michael Breen , Glass Lewis Co , Globe Newswire Gt Biopharma Inc , Gt Biopharma Inc , Exchange Commission On , Institutional Shareholder Services Inc , University Of Minnesota , Company Board Of Directors The , Saratoga Proxy Consulting , Exchange Commission , Institutional Shareholder Services , Glass Lewis , Nasdaq Capital Market , Executive Chairman , Interim Chief Executive Officer , Special Meeting , Reverse Split , Common Stock , Asked Questions , United States Securities , Relations Contacts ,

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Corey Davis , Michael Breen , Drug Administration , Gt Biopharma Inc , Exchange Commission , Globe Newswire Gt Biopharma Inc , University Of Minnesota , Investigational New Drug , Executive Chairman , Interim Chief Executive , Relations Contact ,

GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Jeff Miller , Corey Davis , Jeffrey Miller , Martin Felices , University Of Minnesota , Society For Immunotherapy Of Cancer , Exchange Commission , Globe Newswire Gt Biopharma Inc , Gt Biopharma Inc , Presented Positive Preclinical Data , Targeted Prostate Cancer Treatment During , Associate Professor , Annual Meeting , California November , Prostate Cancer , Consulting Chief Medical Officer , Consulting Chief Scientific , Drs Jeff Miller , Relations Contact ,

GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2023 Financial Results

GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Michael Breen , Corey Davis , Drug Administration , Globe Newswire Gt Biopharma Inc , Development Rd Expenses , Gt Biopharma Inc , Exchange Commission , University Of Minnesota , Executive Chairman , Chief Executive , Relations Contact , Loss Per Share , Average Common Shares Outstanding , Three Months Ended June , Six Months Ended June , Cash Used , Cash Provided , Aktien Sie ,